Considering the essential pathogenic role of Peli1 in driving microglia-mediated neurodegeneration like multiple sclerosis and AD, we proposed that microglial Peli1 may be a critical novel therapeutic target that have clinical potential for the neurodegenerative diseases. This evidence concerns the gene PELI1 and Alzheimer disease.